Melanie Neumann Selected Research

Melanie Neumann Research Topics

Disease

4	Infections 07/2015 - 07/2012
4	Inflammation (Inflammations) 07/2015 - 01/2007
4	Neoplasms (Cancer) 07/2015 - 09/2002
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2013 - 07/2012
3	Infarction (Infarctions) 01/2013 - 01/2007
2	Brain Ischemia (Cerebral Ischemia) 01/2013 - 01/2007
2	Prostatic Neoplasms (Prostate Cancer) 04/2012 - 03/2011
2	Lung Neoplasms (Lung Cancer) 01/2012 - 04/2010
2	Papilloma (Papillomatosis) 05/2007 - 09/2002
1	Colonic Neoplasms (Colon Cancer) 09/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2014
1	Familial encephalopathy with neuroserpin inclusion bodies 10/2014
1	Crimean Hemorrhagic Fever 05/2014
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2013
1	Experimental Nervous System Autoimmune Disease 12/2013
1	Cardiomyopathies (Cardiomyopathy) 06/2013
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 06/2013
1	Amyloidosis 06/2013
1	Bovine Spongiform Encephalopathy (Mad Cow Disease) 06/2013
1	Brain Injuries (Brain Injury) 01/2013
1	Stroke (Strokes) 01/2013
1	Ischemic Stroke 01/2013
1	Leukemia 07/2012
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2011
1	Memory Disorders (Memory Loss) 02/2011
1	Disease Progression 11/2010
1	Cognitive Dysfunction 08/2008
1	Atherosclerotic Plaque (Atheroma) 08/2008
1	Hyperplasia 05/2007
1	Skin Neoplasms (Skin Cancer) 05/2007
1	Ischemia 01/2007
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2007
1	Alopecia (Baldness) 10/2003
1	Carcinogenesis 09/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2002
1	Adenoma (Adenomas) 09/2002

Drug/Important Bio-Agent (IBA)

4	PrionsIBA 12/2013 - 07/2012
3	Protein Isoforms (Isoforms)IBA 07/2015 - 05/2007
3	Prion ProteinsIBA 12/2013 - 11/2010
3	ProstaglandinsIBA 05/2007 - 09/2002
2	NeuroserpinIBA 10/2014 - 01/2013
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2007 - 10/2003
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2003 - 09/2002
1	Peptide Initiation Factors (Initiation Factor)IBA 07/2015
1	deoxyhypusine hydroxylaseIBA 07/2015
1	deoxyhypusine synthaseIBA 07/2015
1	hypusineIBA 07/2015
1	eIF-5A2IBA 07/2015
1	EnzymesIBA 07/2015
1	Proteins (Proteins, Gene)FDA Link 10/2014
1	PolymersIBA 10/2014
1	LectinsIBA 10/2014
1	InterferonsIBA 08/2014
1	favipiravirIBA 05/2014
1	umifenovirIBA 05/2014
1	Ribavirin (Virazole)FDA LinkGeneric 05/2014
1	Transaminases (Aminotransferases)IBA 05/2014
1	Antiviral Agents (Antivirals)IBA 05/2014
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 05/2014
1	Amyloid (Amyloid Fibrils)IBA 06/2013
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2013
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2013
1	SmokeIBA 01/2012
1	Fluoxetine (Prozac)FDA LinkGeneric 02/2011
1	Nicotine FDA Link 04/2010
1	CholesterolIBA 08/2008
1	Keratin-5 (Keratin 5)IBA 05/2007
1	Prostaglandin-E SynthasesIBA 05/2007
1	Prostaglandins EIBA 05/2007
1	Bromodeoxyuridine (BrdU)IBA 01/2007
1	Minocycline (Cyclops)FDA LinkGeneric 01/2007
1	IsoenzymesIBA 10/2003
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2003
1	valdecoxib (Bextra)FDA Link 10/2003
1	anthraceneIBA 09/2002
1	CarcinogensIBA 09/2002
1	phorbolIBA 09/2002

Therapy/Procedure

1	Aftercare (After-Treatment) 09/2017
1	Intravenous Administration 01/2013
1	Therapeutics 04/2012
1	Complementary Therapies (Alternative Medicine) 03/2011
1	Injections 08/2008
1	Cranial Irradiation 01/2007
1	Chemoprevention 09/2002